Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options

Methods Mol Biol. 2020:2069:229-251. doi: 10.1007/978-1-4939-9849-4_16.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.

Keywords: Bacteremia; Community acquired; Hospital acquired; Lung infection; Methicillin-resistant Staphylococcus aureus.

Publication types

  • Review

MeSH terms

  • Community-Acquired Infections* / epidemiology
  • Community-Acquired Infections* / metabolism
  • Community-Acquired Infections* / therapy
  • Cystic Fibrosis* / epidemiology
  • Cystic Fibrosis* / metabolism
  • Humans
  • Methicillin-Resistant Staphylococcus aureus* / metabolism
  • Methicillin-Resistant Staphylococcus aureus* / pathogenicity
  • Respiratory Tract Infections* / epidemiology
  • Respiratory Tract Infections* / metabolism
  • Respiratory Tract Infections* / therapy
  • Soft Tissue Infections* / epidemiology
  • Soft Tissue Infections* / metabolism
  • Soft Tissue Infections* / therapy
  • Staphylococcal Infections* / epidemiology
  • Staphylococcal Infections* / metabolism
  • Staphylococcal Infections* / therapy
  • Virulence Factors / metabolism

Substances

  • Virulence Factors